164 related articles for article (PubMed ID: 17306453)
1. High throughput proteomic strategies for identifying tumour-associated antigens.
Gunawardana CG; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):110-9. PubMed ID: 17306453
[TBL] [Abstract][Full Text] [Related]
2. Identifying autoantibody signatures in cancer: a promising challenge.
Desmetz C; Maudelonde T; Mangé A; Solassol J
Expert Rev Proteomics; 2009 Aug; 6(4):377-86. PubMed ID: 19681673
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of proteomic strategies to identify antibodies resulting from the humoral immune response to cancer].
Desmetz C; Mangé A; Solassol J
Med Sci (Paris); 2008 Dec; 24(12):1071-6. PubMed ID: 19116117
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the strategies for screening and identifying human tumor antigens.
Wang Y; Yang J; Li Z; Yang S
Curr Protein Pept Sci; 2014; 15(8):819-27. PubMed ID: 25345657
[TBL] [Abstract][Full Text] [Related]
5. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
6. Humoral response to cancer as a tool for biomarker discovery.
Desmetz C; Cortijo C; Mangé A; Solassol J
J Proteomics; 2009 Aug; 72(6):982-8. PubMed ID: 19539066
[TBL] [Abstract][Full Text] [Related]
7. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
Chiriva-Internati M; Cobos E; Kast WM
Int Rev Immunol; 2007; 26(3-4):197-222. PubMed ID: 17558744
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling.
Hardouin J; Lasserre JP; Sylvius L; Joubert-Caron R; Caron M
Ann N Y Acad Sci; 2007 Jun; 1107():223-30. PubMed ID: 17804550
[TBL] [Abstract][Full Text] [Related]
9. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.
Almeida LG; Sakabe NJ; deOliveira AR; Silva MC; Mundstein AS; Cohen T; Chen YT; Chua R; Gurung S; Gnjatic S; Jungbluth AA; Caballero OL; Bairoch A; Kiesler E; White SL; Simpson AJ; Old LJ; Camargo AA; Vasconcelos AT
Nucleic Acids Res; 2009 Jan; 37(Database issue):D816-9. PubMed ID: 18838390
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody profiling for cancer detection.
Qiu J; Hanash S
Clin Lab Med; 2009 Mar; 29(1):31-46. PubMed ID: 19389549
[TBL] [Abstract][Full Text] [Related]
11. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory B7-family molecules in the tumour microenvironment.
Zou W; Chen L
Nat Rev Immunol; 2008 Jun; 8(6):467-77. PubMed ID: 18500231
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the humoral immune response to cancer.
Murphy MA; O'Leary JJ; Cahill DJ
J Proteomics; 2012 Aug; 75(15):4573-9. PubMed ID: 22300580
[TBL] [Abstract][Full Text] [Related]
14. Protein and lysate array technologies in cancer research.
Spurrier B; Honkanen P; Holway A; Kumamoto K; Terashima M; Takenoshita S; Wakabayashi G; Austin J; Nishizuka S
Biotechnol Adv; 2008; 26(4):361-9. PubMed ID: 18514460
[TBL] [Abstract][Full Text] [Related]
15. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).
Sodek KL; Evangelou AI; Ignatchenko A; Agochiya M; Brown TJ; Ringuette MJ; Jurisica I; Kislinger T
Mol Biosyst; 2008 Jul; 4(7):762-73. PubMed ID: 18563251
[TBL] [Abstract][Full Text] [Related]
16. Identification of selectively expressed genes and antigens in CTCL.
Hartmann TB; Mattern E; Wiedemann N; van Doorn R; Willemze R; Niikura T; Hildenbrand R; Schadendorf D; Eichmüller SB
Exp Dermatol; 2008 Apr; 17(4):324-34. PubMed ID: 17979976
[TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma.
Shadidi M; Sørensen D; Dybwad A; Furset G; Sioud M
Int J Oncol; 2008 Jan; 32(1):241-7. PubMed ID: 18097564
[TBL] [Abstract][Full Text] [Related]
18. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
Gunawardana CG; Memari N; Diamandis EP
Clin Biochem; 2009 Mar; 42(4-5):426-9. PubMed ID: 19094976
[TBL] [Abstract][Full Text] [Related]
19. Cancer/testis (CT) antigens: potential targets for immunotherapy.
Caballero OL; Chen YT
Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
[TBL] [Abstract][Full Text] [Related]
20. Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot array.
Canzler U; Bartsch H; Ulitzsch S; Kurien BT; Dorri Y; Scofield RH; Grossmann K; Lehmann W; Pilarsky C; Denz A; Grützmann R; Conrad K; Schmitz M; Rieber EP; Distler W; Bachmann MP
Scand J Immunol; 2009 Jun; 69(6):563-9. PubMed ID: 19439018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
